Research gets real - Public votes determine winner of $100,000 research prize

November 19, 2012

Boston, MA - Robert Green, MD, MPH, has been named the winner of the $100,000 BRIght Futures Prize, after a unique competition in which nearly 6,500 online votes from people across the globe determined the winning project. Dr. Green's project, which will explore the genome sequencing of newborns, emerged as the winner after six weeks of public voting.

"I am grateful for BWH for creating this competition and I am delighted to win. At the same time all three finalists were fantastic and worthy of funding," said Dr. Green. "And I hope we can keep this momentum going so more and more people can get their creative pilot projects funded in this kind of way."

In this unique competition, BWH placed the power to determine what vital medical research gets funded in the hands of those who will eventually benefit from it--the public. For the first BRIght Futures prize, the BWH Biomedical Research Institute (BRI) wanted to award a prestigious seed grant to support research that is compelling and promising, but too preliminary or new to receive conventional external funding. It was intended to generate excitement and motivation within the research community and engage the public around these specific research projects as a way to educate the community about the vast array of innovative research taking place at BWH and to involve the public and patients in a more meaningful way in the process of research.

To initiate the BRIght Future's Prize process, the leadership at the BRI asked researchers to submit proposals for projects that fell into two major categories: Using genetics in clinical care and better using what we know about the immune system across diseases. From the project proposals submitted, two sets of peer reviewers selected three proposals they felt proposed equally outstanding projects to compete for the public's vote.

Green's project focuses on a randomized survey of new parents to find out if DNA sequencing of their newborns would be perceived as useful to them and why. If the expected enthusiasm of the new parents is confirmed, the research team will then conduct a pilot project to obtain sequencing in a small number of newborn babies, and integrate genomic information into their medical care.

In addition to Dr. Green's project the other finalists included a project jointly led by Drs. Phil DeJager and Elizabeth Karlson, whose proposal focused on using genetics and electronic health records to treat multiple sclerosis and a project led by Dr. Robert Plenge, whose proposal focused on the use of technology to unravel the mysteries of the immune system.

The award was announced at the inaugural Brigham and Women's Hospital (BWH) Research Day on November 15. The day-long celebration featured a discussion on the importance of research; presentations open to the public on today's hottest health topics such as obesity, healthy aging and personalized medicine by world-renowned experts; more than 150 posters illustrating some of the most promising work coming out of BWH's leading labs. A keynote address was provided by Dr. Atul Gawande, award-winning writer and BWH surgeon, entitled "The Century of the System."
-end-
Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH has more than 3.5 million annual patient visits, is the largest birthing center in New England and employs more than 15,000 people. The Brigham's medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care, quality improvement and patient safety initiatives, and its dedication to research, innovation, community engagement and educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving nearly 1,000 physician-investigators and renowned biomedical scientists and faculty supported by $640 million in funding. BWH continually pushes the boundaries of medicine, including building on its legacy in organ transplantation by performing the first face transplants in the U.S. in 2011. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies, OurGenes and the Women's Health Initiative. For more information and resources, please visit BWH's online newsroom.

Brigham and Women's Hospital

Related Genome Sequencing Articles from Brightsurf:

Tracking the SARS-CoV-2 virus with genome sequencing
Dirk Dittmer, PhD, professor of microbiology and immunology at the UNC School of Medicine, is tracking the virus that causes COVID-19 by sequencing the genome of virus samples collected from diagnostic testing.

Genome sequencing accelerates cancer detection
Recent cancer studies have shown that genomic mutations leading to cancer can occur years, or even decades, before a patient is diagnosed.

Whole genome sequencing reveals genetic structural secrets of schizophrenia
UNC School of Medicine scientists have conducted the largest-ever whole genome sequencing study of schizophrenia to provide a more complete picture of the role the human genome plays in this disease.

Using whole-genome sequencing for early identification and containment of AMR pathogens
A study published today examines the evolutionary and epidemiologic history of an epidemic strain of extensively drug-resistant tuberculosis (XDR-TB) -- called LAM4/KZN.

Whole genome sequencing could help save pumas from inbreeding
The first complete genetic sequences of individual mountain lions point the way to better conservation strategies for saving threatened populations of the wild animals.

Researchers move beyond sequencing and create a 3D genome
St. Jude Children's Research Hospital scientists have taken whole genome sequencing to the next level by creating a 3D map of the genome to better understand development and disease.

Clinical utility of rapid whole genome sequencing in neonates with seizures
Clinical utility of rWGS in the evaluation of neonatal seizures.

Viral genome sequencing in the heart of a Lassa outbreak
The first researchers to deploy a mobile nanopore sequencing technology to evaluate viral genomics at the height of a Lassa virus outbreak in 2018 now report their results.

New era for blood transfusions through genome sequencing
In a new study, investigators from Brigham and Women's Hospital and Harvard Medical School, as well as from the New York Blood Center have leveraged the MedSeq Project -- the first randomized trial of whole genome sequencing in healthy adults -- to develop and validate a computer program that can comprehensively and cost-effectively determine differences in individuals' blood types with more than 99 percent accuracy.

Does genome sequencing increase downstream costs?
The MedSeq Project, led by investigators at Brigham Women's Hospital, is the first randomized trial to provide whole genome sequencing to both presumably healthy patients as well as those with a known cardiology issue.

Read More: Genome Sequencing News and Genome Sequencing Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.